Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
FEMALE
Healthy Volunteers
NCT06610162

Thermogenenic Responses to Fasting and Overfeeding in Women

Led by University of Colorado, Denver · Updated on 2025-04-30

56

Participants Needed

1

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increases the risk of chronic metabolic diseases such as heart disease and diabetes. The increase in weight and body fat with menopause may be due to changes in metabolism related to the loss of estrogen. This study plans to compare how the metabolism of premenopausal and postmenopausal women responds to changes in energy intake. The investigators will compare the changes in energy expenditure that occur during a period of acute fasting (24 hours) and a period of consuming excess calories (overfeeding).

CONDITIONS

Official Title

Thermogenenic Responses to Fasting and Overfeeding in Women

Who Can Participate

Age: 18Years - 65Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Premenopausal women aged 18 to 45 years with regular menstrual cycles (no missed cycles in the past year and cycle length 25-35 days)
  • Postmenopausal women with no menstrual periods for at least 12 months and follicular stimulating hormone (FSH) levels �3750 mIU/ml
  • Women within 2 years of their final menstrual period are preferred
Not Eligible

You will not qualify if you...

  • Body mass index greater than 30 kg/m2
  • Diabetes with fasting glucose greater than 126 mg/dL
  • Thyroid dysfunction with thyroid stimulating hormone (TSH) less than 0.5 or greater than 5.0 mU/L unless treated and stable
  • Uncontrolled hypertension with resting systolic blood pressure over 150 mmHg or diastolic over 90 mmHg unless treated and stable
  • Postmenopausal women with history or current use of estrogen-based hormonal therapy
  • Postmenopausal women who have had surgical menopause
  • Premenopausal women currently using hormonal contraceptives or used them within the past 6 months
  • Premenopausal women who are pregnant, breastfeeding, or planning to become pregnant during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States, 80045

Actively Recruiting

Loading map...

Research Team

E

Edward L Melanson, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here